Stay updated on GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial page.

Latest updates to the GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now shows a 403 Forbidden error page with a minimal header and a Home link, indicating the study record is currently inaccessible. The substantive study content that was previously visible appears removed or blocked.SummaryDifference19%

- Check37 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page previously showing an error has been updated to display the complete study record for NCT03161379. The new content includes study overview, conditions, interventions, outcomes, enrollment and locations, investigators, and links to related documents.SummaryDifference55%

- Check59 days agoChange DetectedThe page’s revision label updates from v3.6.4 to v3.6.5, indicating a minor update to the study record.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page shows a new revision number, indicating a small site update rather than changes to study details. This suggests a patch or maintenance update without affecting the study information.SummaryDifference0.1%

- Check94 days agoChange DetectedThe page shows a new revision tag, changing from v3.6.2 to v3.6.3, indicating a minor update to the study record display.SummaryDifference0.1%

Stay in the know with updates to GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial page.